ClinicalTrials.gov
public full text
Public Domain
AZD6765 Severe Major Depressive Disorder (MDD) IV
The purpose of this research study is to determine whether AZD6765 has an effect on the patient's depression when taken together with current depression medication. In addition, information will be gathered on how well AZD6765 is tolerated, investigate the levels of AZD6765 and the levels of the current depression medication in the blood. In addition, the research staff will determine if AZD6765 has any mood or calming effects (how you feel).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- This is a Study to Determine the Antidepressant Effects of AZD6765#838633
- AZD6765 for Treatment Resistant Depression#1126527
- A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH#869273
- Measurement-Based Care Vs. Standard Care for Major Depressive Disorder#886000
- Impact of Information Strategy Based on Booklet on Anxiety in Family in ICU#880185
Record · ID 1085790
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive